# OnCo record nct05024097 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05024097/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05024097", "NCT05024097" ;
  schema:name "A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for"@en ;
  schema:alternateName "PANTHER"@en ;
  schema:description "A phase 2 trial of zimberelimab in colorectal cancer, run by Weill Medical College of Cornell University, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05024097/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05024097> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/zimberelimab/> ;
  onco:companies <https://onco.cc/companies/arcus-biosciences/> .